[BMRN] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[BMRN] BioMarin Pharmaceutical Inc.
Announcement Date
26-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -49.54%
YoY- 8,282.73%
Quarter Report
BMRN's Result
BMRN's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 646,207 537,538 449,810 452,117 454,443 353,214 358,305 10.32%
PBT 19,327 -17,558 -66,574 -40,185 -9,781 -43,311 54,598 -15.88%
Tax -1,048 -17,309 -8,676 -62,284 -24,805 -39,661 105,990 -
NP 20,375 -249 -57,898 22,099 15,024 -3,650 -51,392 -
Tax Rate 5.42% - - - - - -194.13% -
Total Cost 625,832 537,787 507,708 430,018 439,419 356,864 409,697 7.31%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 3.15 -0.05 -12.87 4.89 3.31 -1.03 -14.34 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 0.11 -0.00 -0.32 0.12 0.08 -0.02 -0.29 -
EPS Diluted 0.11 -0.00 -0.32 0.12 0.08 -0.02 -0.29 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.